1-2406784-C-G

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2

The NM_002617.4(PEX10):​c.712G>C​(p.Gly238Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00115 in 1,610,650 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G238S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0014 ( 1 hom., cov: 34)
Exomes 𝑓: 0.0011 ( 3 hom. )

Consequence

PEX10
NM_002617.4 missense

Scores

6
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:3

Conservation

PhyloP100: 0.469

Publications

5 publications found
Variant links:
Genes affected
PEX10 (HGNC:8851): (peroxisomal biogenesis factor 10) This gene encodes a protein involved in import of peroxisomal matrix proteins. This protein localizes to the peroxisomal membrane. Mutations in this gene result in phenotypes within the Zellweger spectrum of peroxisomal biogenesis disorders, ranging from neonatal adrenoleukodystrophy to Zellweger syndrome. Alternative splicing results in two transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
PEX10 Gene-Disease associations (from GenCC):
  • peroxisome biogenesis disorder
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • peroxisome biogenesis disorder 6A (Zellweger)
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Myriad Women’s Health
  • peroxisome biogenesis disorder 6B
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • autosomal recessive ataxia due to PEX10 deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Zellweger spectrum disorders
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010670394).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00138 (210/152332) while in subpopulation NFE AF = 0.00209 (142/68030). AF 95% confidence interval is 0.00181. There are 1 homozygotes in GnomAd4. There are 118 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PEX10NM_002617.4 linkc.712G>C p.Gly238Arg missense_variant Exon 4 of 6 ENST00000447513.7 NP_002608.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PEX10ENST00000447513.7 linkc.712G>C p.Gly238Arg missense_variant Exon 4 of 6 1 NM_002617.4 ENSP00000407922.2

Frequencies

GnomAD3 genomes
AF:
0.00138
AC:
210
AN:
152214
Hom.:
1
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000193
Gnomad AMI
AF:
0.0219
Gnomad AMR
AF:
0.000916
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000828
Gnomad FIN
AF:
0.000565
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00209
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00129
AC:
312
AN:
241814
AF XY:
0.00136
show subpopulations
Gnomad AFR exome
AF:
0.000266
Gnomad AMR exome
AF:
0.00153
Gnomad ASJ exome
AF:
0.00194
Gnomad EAS exome
AF:
0.0000555
Gnomad FIN exome
AF:
0.000196
Gnomad NFE exome
AF:
0.00191
Gnomad OTH exome
AF:
0.00204
GnomAD4 exome
AF:
0.00113
AC:
1643
AN:
1458318
Hom.:
3
Cov.:
35
AF XY:
0.00116
AC XY:
844
AN XY:
725264
show subpopulations
African (AFR)
AF:
0.000179
AC:
6
AN:
33446
American (AMR)
AF:
0.00142
AC:
63
AN:
44382
Ashkenazi Jewish (ASJ)
AF:
0.00215
AC:
56
AN:
26058
East Asian (EAS)
AF:
0.0000253
AC:
1
AN:
39604
South Asian (SAS)
AF:
0.000513
AC:
44
AN:
85784
European-Finnish (FIN)
AF:
0.000326
AC:
17
AN:
52068
Middle Eastern (MID)
AF:
0.00798
AC:
46
AN:
5762
European-Non Finnish (NFE)
AF:
0.00119
AC:
1318
AN:
1110990
Other (OTH)
AF:
0.00153
AC:
92
AN:
60224
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
108
216
325
433
541
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00138
AC:
210
AN:
152332
Hom.:
1
Cov.:
34
AF XY:
0.00158
AC XY:
118
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.000192
AC:
8
AN:
41570
American (AMR)
AF:
0.000914
AC:
14
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00202
AC:
7
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.000829
AC:
4
AN:
4826
European-Finnish (FIN)
AF:
0.000565
AC:
6
AN:
10622
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00209
AC:
142
AN:
68030
Other (OTH)
AF:
0.00331
AC:
7
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
10
19
29
38
48
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00144
Hom.:
0
Bravo
AF:
0.00136
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.000455
AC:
2
ESP6500EA
AF:
0.00128
AC:
11
ExAC
AF:
0.00116
AC:
141

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:5Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Peroxisome biogenesis disorder 6A (Zellweger) Uncertain:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

May 18, 2021
Genome-Nilou Lab
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Uncertain:2
Jul 19, 2023
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

BS1 -

Sep 18, 2018
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Peroxisome biogenesis disorder 6A (Zellweger);C3553948:Peroxisome biogenesis disorder 6B Uncertain:1
Oct 31, 2018
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

PEX10-related disorder Benign:1
Mar 30, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Zellweger spectrum disorders Benign:1
Nov 11, 2019
Natera, Inc.
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Peroxisome biogenesis disorder, complementation group 7 Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.22
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
15
DANN
Uncertain
0.99
DEOGEN2
Benign
0.15
.;T;T
Eigen
Benign
-0.091
Eigen_PC
Benign
-0.17
FATHMM_MKL
Uncertain
0.80
D
LIST_S2
Uncertain
0.93
D;D;D
M_CAP
Uncertain
0.18
D
MetaRNN
Benign
0.011
T;T;T
MetaSVM
Benign
-0.47
T
MutationAssessor
Uncertain
2.2
.;M;.
PhyloP100
0.47
PrimateAI
Benign
0.39
T
PROVEAN
Benign
-1.2
N;N;N
REVEL
Uncertain
0.34
Sift
Benign
0.19
T;T;T
Sift4G
Benign
0.11
T;T;T
Polyphen
0.82
P;P;.
Vest4
0.31
MVP
0.84
MPC
0.22
ClinPred
0.038
T
GERP RS
-0.23
Varity_R
0.058
gMVP
0.57
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61736380; hg19: chr1-2338223; API